The HLA-G/ILT2 pathway modulates CD8 T cell effector function in gastric cancer

被引：0
|
作者：
Vaquero Yuste, Christian [1 ]
Molina Alejandre, Marta [1 ]
Juarez, Ignacio [1 ]
Gonzalo Jimenez, Diego Jose [1 ]
Gutierrez Calvo, Alberto [2 ]
Lopez Garcia, Adela [2 ]
Gomez Sanz, Remedios [2 ]
Fernandez Cruz, Eduardo [3 ]
Rodriguez Sainz, Carmen [3 ]
Arnaiz Villena, Antonio [1 ]
Martin Villa, Jose Manuel [1 ]
机构：
[1] Univ Complutense Madrid, Fac Med, Dept Immunol Oftalmol & ORL, Madrid, Spain
[2] Hosp Univ Principe de Asturias, Madrid, Spain
[3] Hlth Res Inst Gregorio Maranon, Madrid, Spain
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Biomarkers; cancer immunology; checkpoint inhibition; immune regulation and therapy;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-0896
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [1] Effect of the HLA-G/ILT2 pathway as an immune system checkpoint in gastric cancer
    Vaquero-Yuste, Christian
    Aguilar Sopena, Oscar
    Lasa-Unzue, Inmaculada
    Lopez-Garcia, Adela
    Gomez-Sanz, Remedios
    Gutierrez-Calvo, Alberto
    Roda Navarro, Pedro
    Manuel Martin-Villa, Jose
    Juarez, Ignacio
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 737 - 737
  • [2] HLA-G/ILT2 signaling on the path to tolerance
    Wang, Ping
    Greenland, John R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (06): : 852 - 853
  • [3] Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary
    Schwich, Esther
    Ho, Gia-Gia T.
    LeMaoult, Joel
    Bade-Doeding, Christina
    Carosella, Edgardo D.
    Horn, Peter A.
    Rebmann, Vera
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [4] Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction
    Naji, A.
    Menier, C.
    Maki, G.
    Carosella, E. D.
    Rouas-Freiss, N.
    LEUKEMIA, 2012, 26 (08) : 1889 - 1892
  • [5] Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
    Rouas-Freiss, Nathalie
    LeMaoult, Joel
    Verine, Jerome
    Tronik-Le Roux, Diana
    Culine, Stephane
    Hennequin, Christophe
    Desgrandchamps, Francois
    Carosella, Edgardo D.
    ONCOIMMUNOLOGY, 2017, 6 (09):
  • [6] Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction
    A Naji
    C Menier
    G Maki
    E D Carosella
    N Rouas-Freiss
    Leukemia, 2012, 26 : 1889 - 1892
  • [7] Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2
    Urosevic, M
    Kamarashev, J
    Burg, G
    Dummer, R
    BLOOD, 2004, 103 (05) : 1796 - 1798
  • [8] Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function
    Ince, MN
    Harnisch, B
    Xu, Z
    Lee, SK
    Lange, C
    Moretta, L
    Lederman, M
    Lieberman, J
    IMMUNOLOGY, 2004, 112 (04) : 531 - 542
  • [9] Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G
    Shiroishi, M
    Tsumoto, K
    Amano, K
    Shirakihara, Y
    Colonna, M
    Braud, VM
    Allan, DSJ
    Makadzange, A
    Rowland-Jones, S
    Willcox, B
    Jones, EY
    van der Merwe, PA
    Kumagai, I
    Maenaka, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) : 8856 - 8861
  • [10] Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients
    Durmanova, Vladimira
    Tedla, Miroslav
    Rada, Dusan
    Bandzuchova, Helena
    Kuba, Daniel
    Suchankova, Magda
    Ocenasova, Agata
    Bucova, Maria
    DISEASES, 2024, 12 (02)
12345